» Articles » PMID: 15530852

TIMP-1 Inhibits Microvascular Endothelial Cell Migration by MMP-dependent and MMP-independent Mechanisms

Overview
Journal Exp Cell Res
Specialty Cell Biology
Date 2004 Nov 9
PMID 15530852
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

It was reported over a decade ago that tissue inhibitor of metalloproteinases-1 (TIMP-1) suppresses angiogenesis in experimental models but the mechanism is still incompletely understood. This in vitro study focused on the molecular basis of TIMP-1-mediated inhibition of endothelial cell (EC) migration, a key step in the angiogenic process. Both recombinant human TIMP-1 and the synthetic MMP inhibitors, GM6001 and MMP-2-MMP-9 Inhibitor III, suppressed migration of human dermal microvascular endothelial cells (HDMVEC) in a dose-dependent fashion. The MMP-dependent inhibition of migration was associated with increased expression of the junctional adhesion proteins, VE-cadherin and PECAM-1, and VE-cadherin accumulation at cell-cell junctions. TIMP-1 also caused MMP-independent dephosphorylation of focal adhesion kinase (FAK) (pY397) and paxillin, which was associated with reduced number of F-actin stress fibers and focal adhesions. Moreover, TIMP-1 stimulated expression of PTEN that has been shown to reduce phosphorylation of FAK and inhibit cell migration. Our data suggest that TIMP-1 inhibits HDMVEC migration through MMP-dependent stimulation of VE-cadherin and MMP-independent stimulation of PTEN with subsequent dephosphorylation of FAK and cytoskeletal remodeling.

Citing Articles

Cardiometabolic biomarker patterns associated with cardiac MRI defined fibrosis and microvascular dysfunction in patients with heart failure with preserved ejection fraction.

Siggins C, Pan J, Loffler A, Yang Y, Shaw P, Balfour Jr P Front Cardiovasc Med. 2024; 11:1334226.

PMID: 38500750 PMC: 10945015. DOI: 10.3389/fcvm.2024.1334226.


Matrix metalloproteinases and tissue inhibitors in multiple myeloma: promote or inhibit?.

Li Y, Zhang L, Xiang Y, Li D, Zhang J Front Oncol. 2023; 13:1127407.

PMID: 37823051 PMC: 10562598. DOI: 10.3389/fonc.2023.1127407.


Vascular senescence and leak are features of the early breakdown of the blood-brain barrier in Alzheimer's disease models.

Ting K, Coleman P, Kim H, Zhao Y, Mulangala J, Cheng N Geroscience. 2023; 45(6):3307-3331.

PMID: 37782439 PMC: 10643714. DOI: 10.1007/s11357-023-00927-x.


Cytoskeleton disruption by the metabolic inhibitor 3-bromopyruvate: implications in cancer therapy.

Azevedo-Silva J, Tavares-Valente D, Almeida A, Queiros O, Baltazar F, Ko Y Med Oncol. 2022; 39(9):121.

PMID: 35716210 DOI: 10.1007/s12032-022-01712-0.


β-Toxin Exerts Anti-angiogenic Effects by Inhibiting Re-endothelialization and Neovessel Formation.

Tran P, Tang S, Salgado-Pabon W Front Microbiol. 2022; 13:840236.

PMID: 35185854 PMC: 8851161. DOI: 10.3389/fmicb.2022.840236.